SavedAdd your journal

Journals / ANKEM Dergisi / 2014 / Cilt: 28 - Sayı: 2

Clinical Use of Posaconazole, a Second Generation Triazole in Veterinary Medicine

İKİNCİ KUŞAK TRİAZOL TÜREVİ ANTİMİKOTİK POSAKONAZOLÜN VETERİNER HEKİMLİK ALANINDA KLİNİK KULLANIMI

Efrahim SARGIN
SİNEM ÜLGEN
Mehmet Erman OR
Pages
72–75
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, it is aimed to enlighten the clinical use of posaconazole in veterinary practice.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Fungal inf ections are considerable problems especially in immunosupressed patients.
📊
Key Findings & Data:Common use of current classes of antif ungal agents leads to development of drug resistance.
💡
Conclusion & Impact:In this review, it is aimed to enlighten the clinical use of posaconazole in veterinary practice.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Fungal inf ections are considerable problems especially in immunosupressed patients. Common use of current classes of antif ungal agents leads to development of drug resistance. Particularly in persistent mycosis, use of new-developed antimyco- tic agents may be a new solution in treatment period. Clinical eff icacy of alone or combined use of posaconazole, which causes an inhibition of the synthesis of the primer sterol, ergosterol, in the cell membrane of f ungal agent, is conf irmed with current studies. In this review, it is aimed to enlighten the clinical use of posaconazole in veterinary practice.

Özet

Fungal inf eksiyonlar özellikle bağışıklık sistemi baskılanmış hastalarda önemli bir sorundur. Aynı zamanda bilinen antimikotiklerin kullanımı da mantar etkenlerinin bu antimikotik ilaçlara karşı direnç oluşumuna neden olmaktadır. Özellikle inatçı mikozlarda yeni antimikotiklerin kullanımı tedavi aşamasında bu şekilde oluşabilecek engelleri ortadan kaldırmaya yönelik yeni bir çözüm olabilir. Etkisini mantar hücre zarındaki primer sterol olan ergosterolün sentezini inhibe ederek gerçek- leştiren ikinci kuşak bir triazol türevi olan posakonazolün sistemik ve diğer mikotik inf eksiyonlarda tek başına veya diğer antimikotik ajanlarla kombine olarak kullanımı güncel çalışmalarla desteklenmektedir. Bu derlemede veteriner hekimlik prati- ğinde posakonazol kullanımına yönelik bilgi verilmektedir.

🔖

Cite This Article

SARGIN, E., ÜLGEN, S., OR, M. E. (2014). Clinical Use of Posaconazole, a Second Generation Triazole in Veterinary Medicine. ANKEM Dergisi, Cilt: 28 - Sayı: 2, 72–75. https://ajindex.com/articles/148033

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Barachetti L, Mortellaro CM, Di Giancamillo M et al. Bilateral orbital and nasal aspergillosis in a cat, Vet Ophthalmol 2009;12(3):176-82.
  2. Bueid A, Howard SJ, Moore CB et al. Azole anti- fungal resistance in Aspergillus fumigatus: 2008 and 2009, J Antimicrob Chemother 2010;65(10):2116-8.
  3. Calvo E, Pastor FJ, Rodriguez MM, Mayayo E, Salas V, Guarro J. Murine model of a disseminated infection by the novel fungus Fonsecaea monop- hora and successful treatment with posaconazole, Antimicrob Agents Chemother 2010;54(2):919-23.
  4. Evans N, Gunew M, Marshal R, Martin P, Barrs V. Focal pulmonary granuloma caused by Cladophialophora bantiana in a domestic short haired cat, Med Mycol 2011;49(2):194-7.
  5. Galhardo MCG, De Oliveira RMZ, Do Volle ACF et al. Molecular epidemiology and antifungal sus- ceptibility patterns of Sporothrix schenckii isola- tes from a cat-transmitted epidemic of sporotric- hosis in Rio de Janeiro, Brazil, Med Mycol 2008;46(2):141-51.
  6. Herrin KV, Miranda A, Loebenberg D. Posaconazole therapy for systemic coccidioidomycosis in a chimpanzee (Pan troglodytes): a case report, Mycoses 2005;48(6):447-52.
  7. Hilton H, Galuppo L, Puchalski SM et al. Successful treatment of invasive pulmonary aspergillosis in a neonatal foal, J Vet Internal Med 2009;23(2):375-8.
  8. Howard SJ, Cerar D, Anderson MJ et al. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure, Emerg Inf ect Dis 2009;15(7):1068-76.
  9. Kablan ANM, Or ME, Uysal A. Veteriner pratiğin- de geniş antifungal spektrumlu triazol: vorikona- zol, ANKEM Derg 2009;23(3):149-53
  10. Krockenberger MB, Martin P, Halliday C, Rothwell TLW, Clarke K, Malik R. Localised Microsphaeropsis arundinis infection of the subcutis of a cat, J Feline Med Surg 2010;12(3):231-6.
  11. Kluger EK, Della Torre PK, Martin P, Krockenberger MB, Malik R. Concurrent Fusarium chlamydospo- rum and Microsphaeropsis arundinis infections in a cat, J Feline Med Surg 2004;6(4):271-7.
  12. Lozano-Chiu M, Arikan S, Paetznick VL, Anaissie EJ,